The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab. (Q44741830)
Jump to navigation
Jump to search
scientific article published in January 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab. |
scientific article published in January 2004 |
Statements
The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab (English)
Cornelis G ter Meulen
Cor W M Jacobs
Jack F M Wetzels
Ina S Klasen
Andries J Hoitsma